Literature DB >> 4006916

Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells.

R Zakut-Houri, B Bienz-Tadmor, D Givol, M Oren.   

Abstract

A 2.5-kb cDNA clone for human p53 tumor antigen has been isolated. This clone contains the entire coding region including 135 bp upstream of the first ATG. Comparison of the nucleotide sequence of human p53 and mouse p53 demonstrates that the first ATG in human p53 corresponds to the second ATG (codon No. 4) in mouse p53. The human p53 comprises 393 residues and is longer than the mouse p53 due to six additional codons present at the region corresponding to exon 4 of the mouse p53 gene. The DNA sequence homology between the coding regions of mouse and human p53 is 81% and the conservation of homology is not equally distributed along the molecule. When inserted into SV40-based expression vectors the human p53 cDNA successfully directs the production of a polypeptide with an apparent mol. wt. of 55 kd which can be precipitated by monoclonal antibodies to p53.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4006916      PMCID: PMC554332          DOI: 10.1002/j.1460-2075.1985.tb03768.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  28 in total

1.  Monoclonal antibodies specific for simian virus 40 tumor antigens.

Authors:  E Harlow; L V Crawford; D C Pim; N M Williamson
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

2.  SV40-53K antigen: a possible role for 53K in normal cells.

Authors:  J Milner; S Milner
Journal:  Virology       Date:  1981-07-30       Impact factor: 3.616

3.  SV40-transformed simian cells support the replication of early SV40 mutants.

Authors:  Y Gluzman
Journal:  Cell       Date:  1981-01       Impact factor: 41.582

4.  Microinjection of monoclonal antibody to protein p53 inhibits serum-induced DNA synthesis in 3T3 cells.

Authors:  W E Mercer; D Nelson; A B DeLeo; L J Old; R Baserga
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

5.  Coding potential and regulatory signals of the polyoma virus genome.

Authors:  E Soeda; J R Arrand; N Smolar; J E Walsh; B E Griffin
Journal:  Nature       Date:  1980-01-31       Impact factor: 49.962

6.  Nucleotide sequences from the adenovirus-2 genome.

Authors:  T R Gingeras; D Sciaky; R E Gelinas; J Bing-Dong; C E Yen; M M Kelly; P A Bullock; B L Parsons; K E O'Neill; R J Roberts
Journal:  J Biol Chem       Date:  1982-11-25       Impact factor: 5.157

7.  Characterization of tau antigens isolated from uninfected and simian virus 40-infected monkey cells and papovavirus-transformed cells.

Authors:  D T Simmons
Journal:  J Virol       Date:  1980-11       Impact factor: 5.103

8.  Monoclonal antibodies against simian virus 40 T antigens: evidence for distinct sublcasses of large T antigen and for similarities among nonviral T antigens.

Authors:  E G Gurney; R O Harrison; J Fenno
Journal:  J Virol       Date:  1980-06       Impact factor: 5.103

9.  The amino acid sequence of murine p53 determined from a c-DNA clone.

Authors:  D Pennica; D V Goeddel; J S Hayflick; N C Reich; C W Anderson; A J Levine
Journal:  Virology       Date:  1984-04-30       Impact factor: 3.616

10.  A cDNA cloning vector that permits expression of cDNA inserts in mammalian cells.

Authors:  H Okayama; P Berg
Journal:  Mol Cell Biol       Date:  1983-02       Impact factor: 4.272

View more
  65 in total

1.  Length and secondary structure of the 5' non-coding regions of mouse p53 mRNA transcripts - mouse as a model organism for p53 gene expression studies.

Authors:  Joanna Szpotkowska; Agata Swiatkowska; Jerzy Ciesiołka
Journal:  RNA Biol       Date:  2018-12-20       Impact factor: 4.652

Review 2.  Molecular genetics of neurological tumours.

Authors:  R Y Chung; B R Seizinger
Journal:  J Med Genet       Date:  1992-06       Impact factor: 6.318

3.  Plateau distributions of DNA fragment lengths produced by extended light exposure of extranuclear photosensitizers in human cells.

Authors:  E Kvam; T Stokke; J Moan; H B Steen
Journal:  Nucleic Acids Res       Date:  1992-12-25       Impact factor: 16.971

4.  Structural alteration in the MYB protooncogene and deletion within the gene encoding alpha-type protein kinase C in human melanoma cell lines.

Authors:  A J Linnenbach; K Huebner; E P Reddy; M Herlyn; A H Parmiter; P C Nowell; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

5.  Simian virus 40 can overcome the antiproliferative effect of wild-type p53 in the absence of stable large T antigen-p53 binding.

Authors:  D Michael-Michalovitz; F Yehiely; E Gottlieb; M Oren
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

6.  Negative effects of wild-type p53 and s-Myc on cellular growth and tumorigenicity of glioma cells. Implication of the tumor suppressor genes for gene therapy.

Authors:  A Asai; Y Miyagi; A Sugiyama; M Gamanuma; S H Hong; S Takamoto; K Nomura; M Matsutani; K Takakura; Y Kuchino
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

7.  Functional interaction between DP-1 and p53.

Authors:  T S Sørensen; R Girling; C W Lee; J Gannon; L R Bandara; N B La Thangue
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

Review 8.  The first 30 years of p53: growing ever more complex.

Authors:  Arnold J Levine; Moshe Oren
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

9.  Oncogene amplification in breast cancer.

Authors:  M Donovan-Peluso; A M Contento; H Tobon; B Ripepi; J Locker
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

10.  Clinical and genetic characteristics of Japanese Burkitt lymphomas with or without leukemic presentation.

Authors:  Takeshi Namiki; Akiko Sakashita; Hirofumi Kobayashi; Nobuo Maseki; Toshiyuki Izumo; Yoshihiro Komada; Shoichi Koizumi; Takaaki Shikano; Atsushi Kikuta; Arata Watanabe; Junji Suzumiya; Masahiro Kikuchi; Yasuhiko Kaneko
Journal:  Int J Hematol       Date:  2003-06       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.